E-LIB Suche - Ergebnisse für: Kaplan, Rick

1

Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, d..:

Leach, Joshua D. G. ; Vlahov, Nikola ; Tsantoulis, Petros...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

2

RAMPART: A phase III multi-arm multi-stage trial of adjuvan..:

Oza, Bhavna ; Frangou, Eleni ; Smith, Ben...
Contemporary Clinical Trials. 108 (2021) - p. 106482 , 2021

Link: https://doi.org/10.1016/..

3

RAMPART: A model for a regulatory-ready academic-led phase ..:

Meade, Angela ; Oza, Bhavna ; Frangou, Eleni...
Contemporary Clinical Trials. 108 (2021) - p. 106481 , 2021

Link: https://doi.org/10.1016/..

4

Effective delivery of Complex Innovative Design (CID) cance..:

Blagden, Sarah P. ; Billingham, Lucinda ; Brown, Louise C....
British Journal of Cancer. 122 (2020) 4 - p. 473-482 , 2020

Link: https://doi.org/10.1038/..

5

Metformin use and risk of cancer in patients with type 2 di..:

Farmer, Ruth E ; Ford, Deborah ; Mathur, Rohini...
International Journal of Epidemiology. 48 (2019) 2 - p. 527-537 , 2019

Link: https://doi.org/10.1093/..

6

Changing the Paradigm—Multistage Multiarm Randomized Trials..:

Lawler, Mark ; Kaplan, Rick ; Wilson, Richard H...
The Oncologist. 20 (2015) 8 - p. 849-851 , 2015

Link: https://doi.org/10.1634/..

7

Selection by Biomarker in Prostate Cancer:

, In: A Practical Guide to Designing Phase II Trials in Oncology,

Kaplan, Rick ; Brown, Sarah - p. 163-173 , 2014

Link: https://doi.org/10.1002/..

8

A Phase I Open-Label, Dose-Escalation, Multi-Institutional ..:

Chiocca, E. Antonio ; Abbed, Khalid M. ; Tatter, Stephen...
Molecular Therapy. 10 (2004) 5 - p. 958-966 , 2004

Link: https://doi.org/10.1016/..

9

INTERVIEW: Reporting the World: Challenges for US Media:

Kaplan, Rick ; Wang, Stephanie
Harvard International Review. 24 (2002) 1 - p. 76-78 , 2002

Link: https://www.jstor.org/st..

10

External Validation of the 2003 Leibovich Prognostic Score ..:

Oza, Bhavna ; Eisen, Tim ; Frangou, Eleni...
https://discovery.ucl.ac.uk/id/eprint/10144485/1/Oza_External%20Validation%20of%20the%202003%20Leibovich%20Prognostic%20Score%20in%20Patients%20Randomly%20Assigned%20to%20SORCE,%20an%20International%20Phase%20III%20Trial%20of%20Adjuvant%20Sorafenib%20in%20Renal%20Cell%20Cancer_AOP.pdf. , 2022

Link: https://discovery.ucl.ac..

11

External Validation of the 2003 Leibovich Prognostic Score ..:

Oza, Bhavna ; Eisen, Tim ; Frangou, Eleni...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148696/. , 2022

Link: http://www.ncbi.nlm.nih...

12

External Validation of the 2003 Leibovich Prognostic Score ..:

Oza, Bhavna ; Eisen, Tim ; Frangou, Eleni...
https://www.repository.cam.ac.uk/handle/1810/334600. , 2022

Link: https://www.repository.c..

13

RAMPART: A phase III multi-arm multi-stage trial of adjuvan..:

Oza, Bhavna ; Frangou, Eleni ; Smith, Ben...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520913/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, d..:

Leach, Joshua D.G ; Vlahov, Nikola ; Tsantoulis, Petros...
https://eprints.gla.ac.uk/243747/1/243747.pdf. , 2021

Link: https://eprints.gla.ac.u..

15

RAMPART : a model for a regulatory-ready academic-led phase..:

Meade, Angela ; Oza, Bhavna ; Frangou, Eleni...
Contemporary Clinical Trials. , 2021

Link: http://hdl.handle.net/10..